These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 23932248)

  • 1. Click conjugated polymeric immuno-nanoparticles for targeted siRNA and antisense oligonucleotide delivery.
    Chan DP; Deleavey GF; Owen SC; Damha MJ; Shoichet MS
    Biomaterials; 2013 Nov; 34(33):8408-15. PubMed ID: 23932248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smart polymeric micelles as nanocarriers for oligonucleotides and siRNA delivery.
    Kataoka K; Itaka K; Nishiyama N; Yamasaki Y; Oishi M; Nagasaki Y
    Nucleic Acids Symp Ser (Oxf); 2005; (49):17-8. PubMed ID: 17150611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA nanocarriers based on methacrylic acid copolymers.
    Felber AE; Castagner B; Elsabahy M; Deleavey GF; Damha MJ; Leroux JC
    J Control Release; 2011 May; 152(1):159-67. PubMed ID: 21195736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furan-functionalized co-polymers for targeted drug delivery: characterization, self-assembly and drug encapsulation.
    Shi M; Shoichet MS
    J Biomater Sci Polym Ed; 2008; 19(9):1143-57. PubMed ID: 18727857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers.
    Fattal E; Bochot A
    Int J Pharm; 2008 Dec; 364(2):237-48. PubMed ID: 18619528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing chemically modified oligonucleotides for targeted gene silencing.
    Deleavey GF; Damha MJ
    Chem Biol; 2012 Aug; 19(8):937-54. PubMed ID: 22921062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted polymeric micelles for siRNA treatment of experimental cancer by intravenous injection.
    Christie RJ; Matsumoto Y; Miyata K; Nomoto T; Fukushima S; Osada K; Halnaut J; Pittella F; Kim HJ; Nishiyama N; Kataoka K
    ACS Nano; 2012 Jun; 6(6):5174-89. PubMed ID: 22575090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD; Huang L
    Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interactions of amphiphilic antisense oligonucleotides with serum proteins and their effects on in vitro silencing activity.
    Felber AE; Bayó-Puxan N; Deleavey GF; Castagner B; Damha MJ; Leroux JC
    Biomaterials; 2012 Sep; 33(25):5955-65. PubMed ID: 22656448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of antisense oligonucleotides and siRNAs into mammalian cells.
    Sioud M
    Methods Mol Biol; 2009; 487():61-82. PubMed ID: 19301642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.
    Mao CQ; Du JZ; Sun TM; Yao YD; Zhang PZ; Song EW; Wang J
    Biomaterials; 2011 Apr; 32(11):3124-33. PubMed ID: 21277018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
    Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
    ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.
    Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L
    Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer.
    Wang Y; Liu P; Du J; Sun Y; Li F; Duan Y
    J Biomater Sci Polym Ed; 2013; 24(10):1219-32. PubMed ID: 23713424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.
    Liu CW; Lin WJ
    J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-mimetic polymeric micelles for targeted siRNA delivery.
    Xiong XB; Uludağ H; Lavasanifar A
    Biomaterials; 2010 Aug; 31(22):5886-93. PubMed ID: 20427082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
    Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
    J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.